BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?
Highlights • Blooming sign is lower in benign lesions (3.03%) than in malignant lesions (17.9%). • The malignancy rate in ACR3 lesions was
Gespeichert in:
| Veröffentlicht in: | European journal of radiology 2016-02, Vol.85 (2), p.337-345 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 345 |
|---|---|
| container_issue | 2 |
| container_start_page | 337 |
| container_title | European journal of radiology |
| container_volume | 85 |
| creator | Guillaume, Ralphy Taieb, Sophie Ceugnart, Luc Deken-Delannoy, Valerie Faye, Nathalie |
| description | Highlights • Blooming sign is lower in benign lesions (3.03%) than in malignant lesions (17.9%). • The malignancy rate in ACR3 lesions was |
| doi_str_mv | 10.1016/j.ejrad.2015.11.032 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1760897754</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0720048X15301741</els_id><sourcerecordid>1760897754</sourcerecordid><originalsourceid>FETCH-LOGICAL-c414t-638c2d906e720d810c507a696a82847c3df6ff97d0d0112e92d39083816ee9e03</originalsourceid><addsrcrecordid>eNqFUk1v1DAQjRCILoVfgIR85LLLjJ3EDhKg0vKxUhFSC4Kb5bUnXYdsvNjZVuXv8Edxui0HLlzsGevNG795UxRPERYIWL_oFtRF4xYcsFogLkDwe8UMleRzKbm8X8xAcphDqb4fFI9S6gCgKhv-sDjgtVSIQs2K32-XZ0cn50ywT2dL1lPyYUgv2TeT2Lgm5gc_etOzZEMkZrbbGLbRmzHHg2NXazMyv0demn5HLLQ3yaoPYeOHC5b8xcAyl8mnc5krDJlta6LZ0EiRjYGtaJwiu86PNkf-F00cie5-8-Zx8aA1faInt_dh8fX9uy_HH-ennz8sj49O57bEcpzXQlnuGqgpy3YKwVYgTd3URnFVSitcW7dtIx04QOTUcCcaUEJhTdQQiMPi-Z43q_y5ozTqjU-W-t4MFHZJo6xBNVJWZYaKPdTGkFKkVuexbEy81gh6ckd3-sYdPbmjEXV2J1c9u22wW23I_a25syMDXu0BlGVeeoo6WU-DJecj2VG74P_T4PU_9bbPFlrT_6BrSl3YxTz_rEQnrkGfTwsy7QdWAlCWKP4AUi-2_Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1760897754</pqid></control><display><type>article</type><title>BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Guillaume, Ralphy ; Taieb, Sophie ; Ceugnart, Luc ; Deken-Delannoy, Valerie ; Faye, Nathalie</creator><creatorcontrib>Guillaume, Ralphy ; Taieb, Sophie ; Ceugnart, Luc ; Deken-Delannoy, Valerie ; Faye, Nathalie</creatorcontrib><description>Highlights • Blooming sign is lower in benign lesions (3.03%) than in malignant lesions (17.9%). • The malignancy rate in ACR3 lesions was <2% even in high-risk population. • Blooming sign increased MRI performance and may reduce unnecessary biopsy.</description><identifier>ISSN: 0720-048X</identifier><identifier>EISSN: 1872-7727</identifier><identifier>DOI: 10.1016/j.ejrad.2015.11.032</identifier><identifier>PMID: 26781138</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adult ; Aged ; BIRADS 3 ; Blooming sign ; Breast MRI ; Breast Neoplasms - pathology ; Female ; Follow-up ; High-risk women ; Humans ; Magnetic Resonance Imaging - methods ; Middle Aged ; Radiology ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity</subject><ispartof>European journal of radiology, 2016-02, Vol.85 (2), p.337-345</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2015 Elsevier Ireland Ltd</rights><rights>Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c414t-638c2d906e720d810c507a696a82847c3df6ff97d0d0112e92d39083816ee9e03</citedby><cites>FETCH-LOGICAL-c414t-638c2d906e720d810c507a696a82847c3df6ff97d0d0112e92d39083816ee9e03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejrad.2015.11.032$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26781138$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Guillaume, Ralphy</creatorcontrib><creatorcontrib>Taieb, Sophie</creatorcontrib><creatorcontrib>Ceugnart, Luc</creatorcontrib><creatorcontrib>Deken-Delannoy, Valerie</creatorcontrib><creatorcontrib>Faye, Nathalie</creatorcontrib><title>BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?</title><title>European journal of radiology</title><addtitle>Eur J Radiol</addtitle><description>Highlights • Blooming sign is lower in benign lesions (3.03%) than in malignant lesions (17.9%). • The malignancy rate in ACR3 lesions was <2% even in high-risk population. • Blooming sign increased MRI performance and may reduce unnecessary biopsy.</description><subject>Adult</subject><subject>Aged</subject><subject>BIRADS 3</subject><subject>Blooming sign</subject><subject>Breast MRI</subject><subject>Breast Neoplasms - pathology</subject><subject>Female</subject><subject>Follow-up</subject><subject>High-risk women</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Middle Aged</subject><subject>Radiology</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><issn>0720-048X</issn><issn>1872-7727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUk1v1DAQjRCILoVfgIR85LLLjJ3EDhKg0vKxUhFSC4Kb5bUnXYdsvNjZVuXv8Edxui0HLlzsGevNG795UxRPERYIWL_oFtRF4xYcsFogLkDwe8UMleRzKbm8X8xAcphDqb4fFI9S6gCgKhv-sDjgtVSIQs2K32-XZ0cn50ywT2dL1lPyYUgv2TeT2Lgm5gc_etOzZEMkZrbbGLbRmzHHg2NXazMyv0demn5HLLQ3yaoPYeOHC5b8xcAyl8mnc5krDJlta6LZ0EiRjYGtaJwiu86PNkf-F00cie5-8-Zx8aA1faInt_dh8fX9uy_HH-ennz8sj49O57bEcpzXQlnuGqgpy3YKwVYgTd3URnFVSitcW7dtIx04QOTUcCcaUEJhTdQQiMPi-Z43q_y5ozTqjU-W-t4MFHZJo6xBNVJWZYaKPdTGkFKkVuexbEy81gh6ckd3-sYdPbmjEXV2J1c9u22wW23I_a25syMDXu0BlGVeeoo6WU-DJecj2VG74P_T4PU_9bbPFlrT_6BrSl3YxTz_rEQnrkGfTwsy7QdWAlCWKP4AUi-2_Q</recordid><startdate>20160201</startdate><enddate>20160201</enddate><creator>Guillaume, Ralphy</creator><creator>Taieb, Sophie</creator><creator>Ceugnart, Luc</creator><creator>Deken-Delannoy, Valerie</creator><creator>Faye, Nathalie</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160201</creationdate><title>BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?</title><author>Guillaume, Ralphy ; Taieb, Sophie ; Ceugnart, Luc ; Deken-Delannoy, Valerie ; Faye, Nathalie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c414t-638c2d906e720d810c507a696a82847c3df6ff97d0d0112e92d39083816ee9e03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>BIRADS 3</topic><topic>Blooming sign</topic><topic>Breast MRI</topic><topic>Breast Neoplasms - pathology</topic><topic>Female</topic><topic>Follow-up</topic><topic>High-risk women</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Middle Aged</topic><topic>Radiology</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Guillaume, Ralphy</creatorcontrib><creatorcontrib>Taieb, Sophie</creatorcontrib><creatorcontrib>Ceugnart, Luc</creatorcontrib><creatorcontrib>Deken-Delannoy, Valerie</creatorcontrib><creatorcontrib>Faye, Nathalie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Guillaume, Ralphy</au><au>Taieb, Sophie</au><au>Ceugnart, Luc</au><au>Deken-Delannoy, Valerie</au><au>Faye, Nathalie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions?</atitle><jtitle>European journal of radiology</jtitle><addtitle>Eur J Radiol</addtitle><date>2016-02-01</date><risdate>2016</risdate><volume>85</volume><issue>2</issue><spage>337</spage><epage>345</epage><pages>337-345</pages><issn>0720-048X</issn><eissn>1872-7727</eissn><abstract>Highlights • Blooming sign is lower in benign lesions (3.03%) than in malignant lesions (17.9%). • The malignancy rate in ACR3 lesions was <2% even in high-risk population. • Blooming sign increased MRI performance and may reduce unnecessary biopsy.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>26781138</pmid><doi>10.1016/j.ejrad.2015.11.032</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0720-048X |
| ispartof | European journal of radiology, 2016-02, Vol.85 (2), p.337-345 |
| issn | 0720-048X 1872-7727 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1760897754 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Adult Aged BIRADS 3 Blooming sign Breast MRI Breast Neoplasms - pathology Female Follow-up High-risk women Humans Magnetic Resonance Imaging - methods Middle Aged Radiology Reproducibility of Results Retrospective Studies Sensitivity and Specificity |
| title | BIRADS 3 MRI lesions: Was the initial score appropriate and what is the value of the blooming sign as an additional parameter to better characterize these lesions? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A17%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=BIRADS%203%20MRI%20lesions:%20Was%20the%20initial%20score%20appropriate%20and%20what%20is%20the%20value%20of%20the%20blooming%20sign%20as%20an%20additional%20parameter%20to%20better%20characterize%20these%20lesions?&rft.jtitle=European%20journal%20of%20radiology&rft.au=Guillaume,%20Ralphy&rft.date=2016-02-01&rft.volume=85&rft.issue=2&rft.spage=337&rft.epage=345&rft.pages=337-345&rft.issn=0720-048X&rft.eissn=1872-7727&rft_id=info:doi/10.1016/j.ejrad.2015.11.032&rft_dat=%3Cproquest_cross%3E1760897754%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1760897754&rft_id=info:pmid/26781138&rft_els_id=S0720048X15301741&rfr_iscdi=true |